Rosmarinic acid is underestimated as an experimental cardiovascular drug and deserves more attention.
No takes yet. Share an insight, caveat, or question.
Ferreira et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: